These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33428703)

  • 1. MicroRNA-149 is downregulated in Alzheimer's disease and inhibits β-amyloid accumulation and ameliorates neuronal viability through targeting BACE1.
    Du W; Lei C; Dong Y
    Genet Mol Biol; 2021; 44(1):e20200064. PubMed ID: 33428703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Zhang J; Wang R
    Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-15b represses BACE1 expression in sporadic Alzheimer's disease.
    Gong G; An F; Wang Y; Bian M; Yu LJ; Wei C
    Oncotarget; 2017 Oct; 8(53):91551-91557. PubMed ID: 29207665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model.
    Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W
    Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells.
    Zhang N; Li WW; Lv CM; Gao YW; Liu XL; Zhao L
    Neuroreport; 2020 Feb; 31(3):205-212. PubMed ID: 31876684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.
    Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y
    Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-124 acts as a target for Alzheimer's disease by regulating BACE1.
    An F; Gong G; Wang Y; Bian M; Yu L; Wei C
    Oncotarget; 2017 Dec; 8(69):114065-114071. PubMed ID: 29371969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1.
    Li P; Xu Y; Wang B; Huang J; Li Q
    J Neurol Sci; 2020 Jun; 413():116793. PubMed ID: 32251872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-186 is decreased in aged brain and suppresses BACE1 expression.
    Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J
    J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of miR-433 in the diagnosis of Alzheimer's disease and its effect on Aβ-induced neurotoxicity by regulating JAK2.
    Wang R; Zhang J
    Exp Gerontol; 2020 Nov; 141():111080. PubMed ID: 32871216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ
    Ge Y; Song X; Liu J; Liu C; Xu C
    Neurochem Res; 2020 Apr; 45(4):741-751. PubMed ID: 31898085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-132-3p alleviates neuron apoptosis and impairments of learning and memory abilities in Alzheimer's disease by downregulation of HNRNPU stabilized BACE1.
    Qu J; Xiong X; Hujie G; Ren J; Yan L; Ma L
    Cell Cycle; 2021 Nov; 20(21):2309-2320. PubMed ID: 34585626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.
    Yu L; Li H; Liu W; Zhang L; Tian Q; Li H; Li M
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1548. PubMed ID: 33220166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
    Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
    Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
    Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
    Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
    Ji Y; Wang D; Zhang B; Lu H
    J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
    Zhou Y; Ge Y; Liu Q; Li YX; Chao X; Guan JJ; Diwu YC; Zhang Q
    Neuroscience; 2021 Feb; 455():52-64. PubMed ID: 33197504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-200a-3p Mediates Neuroprotection in Alzheimer-Related Deficits and Attenuates Amyloid-Beta Overproduction and Tau Hyperphosphorylation
    Wang L; Liu J; Wang Q; Jiang H; Zeng L; Li Z; Liu R
    Front Pharmacol; 2019; 10():806. PubMed ID: 31379578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.
    Ji Q; Wang X; Cai J; Du X; Sun H; Zhang N
    Curr Neurovasc Res; 2019; 16(5):473-480. PubMed ID: 31713484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis.
    Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W
    J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.